Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
about
Immune checkpoint blockade in infectious diseases.HIV integration sites and implications for maintenance of the reservoir.The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research.Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy.
P2860
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Human Immunodeficiency Virus P ...... essive Antiretroviral Therapy.
@en
type
label
Human Immunodeficiency Virus P ...... essive Antiretroviral Therapy.
@en
prefLabel
Human Immunodeficiency Virus P ...... essive Antiretroviral Therapy.
@en
P2093
P2860
P50
P356
P1476
Human Immunodeficiency Virus P ...... essive Antiretroviral Therapy.
@en
P2093
Ajantha Solomon
Elizabeth Sinclair
Jenny L Anderson
Ma Somsouk
Marisela Killian
Peter Bacchetti
Peter W Hunt
Rebecca Hoh
Rémi Fromentin
Steven G Deeks
P2860
P304
P356
10.1093/INFDIS/JIX039
P407
P577
2017-03-01T00:00:00Z